more information

Category:

Biologically Active Peptides

reference

1. Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint, J.C. Beauvillain, J.M. Conlon, H.A. Bern, and H. Vaudry, Proc. Natl. Acad. Sci. USA, 95, 15803 (1998). (Original)
2. R.S. Ames, H.M. Sarau, J.K. Chambers, R.N. Willette, N.V. Aiyar, A.M. Romanic, C.S. Louden, J.J. Foley, C.F. Sauermelch, R.W. Coatney, Z. Ao, J. Disa, S.D. Holmes, J.M. Stadel, J.D. Martin, W.-S. Liu, G.I. Glover, S. Wilson, D.E. McNulty, C.E. Ellis, N.A. Elshourbagy, U. Shabon, J.J. Trill, D.W.P. Hay, E.H. Ohlstein, D.J. Bergsma, and S.A. Douglas, Nature, 401, 282 (1999). (Pharmacol.)
3. M.R. MacLean, D. Alexander, A. Stirrat, M. Gallagher, S.A. Douglas, E.H. Ohlstein, I. Morecroft, and K. Polland, Br. J. Pharmacol., 130, 201 (2000). (Pharmacol.)
4. N.A. Elshourbagy, S.A. Douglas, U. Shabon, S. Harrison, G. Duddy, J.L. Sechler, Z. Ao, B.E. Maleeff., D. Naselsky, J. Disa, and N.V. Aiyar, Br. J. Pharmacol., 136, 9 (2002). (Original; Monkey)
5. A.P. Davenport and J.J. Maguire, Trends Pharmacol. Ther., 21, 80 (2000). (Review)
6. K.L. Ong, K.S.L. Lam, and B.M.Y. Cheung, Cardiovasc. Drug. Ther., 19, 65 (2005). (Review)
7. T. Sugo and M. Mori, Peptides, 29, 809 (2008). (Review)
8. K.L. Ong, L.Y.F. Wong, and B.M.Y. Cheung, Peptides, 29, 859 (2008). (Review)
9. Z. Carmine and F. Mallamaci, Curr. Opin. Nephrol. Hypertens., 17, 199 (2008). (Review)
10. D. Guidolin, G. Albertin, and D. Ribatti, Peptides, 31, 1219 (2010). (Review)